Monthly Archives: September 2015

The Era of Biosimilars

  A decade ago the focus of the biotech world was on biologicals. The names Humira®, Enbrel®, Lucentis®, Remicade® etc. were common place with analysts accurately predicting billion dollar global sales of these products. In the last five years, while … Continue reading

Posted in November 2011 | Leave a comment